PubMed:32023685 / 432-646
Annnotations
LitCovid-PAS-Enju
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
EnjuParser_T69 | 0-9 | JJ | denotes | Antiviral |
EnjuParser_T70 | 10-15 | NNS | denotes | drugs |
EnjuParser_T71 | 16-24 | RB | denotes | commonly |
EnjuParser_T72 | 25-29 | VBN | denotes | used |
EnjuParser_T73 | 30-32 | IN | denotes | in |
EnjuParser_T74 | 33-41 | JJ | denotes | clinical |
EnjuParser_T75 | 42-50 | NN | denotes | practice |
EnjuParser_T76 | 50-51 | -COMMA- | denotes | , |
EnjuParser_T77 | 52-61 | VBG | denotes | including |
EnjuParser_T78 | 62-75 | NN | denotes | neuraminidase |
EnjuParser_T79 | 76-86 | NNS | denotes | inhibitors |
EnjuParser_T80 | 87-88 | -LRB- | denotes | ( |
EnjuParser_T81 | 88-99 | NN | denotes | oseltamivir |
EnjuParser_T82 | 99-100 | -COMMA- | denotes | , |
EnjuParser_T83 | 101-110 | NN | denotes | paramivir |
EnjuParser_T84 | 110-111 | -COMMA- | denotes | , |
EnjuParser_T85 | 112-121 | NN | denotes | zanamivir |
EnjuParser_T86 | 121-122 | -COMMA- | denotes | , |
EnjuParser_T87 | 123-127 | FW | denotes | etc. |
EnjuParser_T88 | 127-128 | -RRB- | denotes | ) |
EnjuParser_T89 | 128-129 | -COMMA- | denotes | , |
EnjuParser_T90 | 130-141 | NN | denotes | ganciclovir |
EnjuParser_T91 | 141-142 | -COMMA- | denotes | , |
EnjuParser_T92 | 143-152 | NN | denotes | acyclovir |
EnjuParser_T93 | 153-156 | CC | denotes | and |
EnjuParser_T94 | 157-166 | NN | denotes | ribavirin |
EnjuParser_T95 | 166-167 | -COMMA- | denotes | , |
EnjuParser_T96 | 168-171 | VBP | denotes | are |
EnjuParser_T97 | 172-179 | JJ | denotes | invalid |
EnjuParser_T98 | 180-183 | IN | denotes | for |
EnjuParser_T99 | 184-193 | NN | denotes | 2019-nCoV |
EnjuParser_T100 | 194-197 | CC | denotes | and |
EnjuParser_T101 | 198-201 | RB | denotes | not |
EnjuParser_T102 | 202-213 | VBN | denotes | recommended |
EnjuParser_R69 | EnjuParser_T70 | EnjuParser_T69 | arg1Of | drugs,Antiviral |
EnjuParser_R70 | EnjuParser_T72 | EnjuParser_T71 | arg1Of | used,commonly |
EnjuParser_R71 | EnjuParser_T70 | EnjuParser_T72 | arg2Of | drugs,used |
EnjuParser_R72 | EnjuParser_T72 | EnjuParser_T73 | arg1Of | used,in |
EnjuParser_R73 | EnjuParser_T75 | EnjuParser_T73 | arg2Of | practice,in |
EnjuParser_R74 | EnjuParser_T75 | EnjuParser_T74 | arg1Of | practice,clinical |
EnjuParser_R75 | EnjuParser_T70 | EnjuParser_T76 | arg1Of | drugs,"," |
EnjuParser_R76 | EnjuParser_T70 | EnjuParser_T77 | arg1Of | drugs,including |
EnjuParser_R77 | EnjuParser_T89 | EnjuParser_T77 | arg2Of | ",",including |
EnjuParser_R78 | EnjuParser_T79 | EnjuParser_T78 | arg1Of | inhibitors,neuraminidase |
EnjuParser_R79 | EnjuParser_T79 | EnjuParser_T80 | arg1Of | inhibitors,( |
EnjuParser_R80 | EnjuParser_T81 | EnjuParser_T80 | arg2Of | oseltamivir,( |
EnjuParser_R81 | EnjuParser_T88 | EnjuParser_T80 | arg3Of | ),( |
EnjuParser_R82 | EnjuParser_T81 | EnjuParser_T82 | arg1Of | oseltamivir,"," |
EnjuParser_R83 | EnjuParser_T83 | EnjuParser_T82 | arg2Of | paramivir,"," |
EnjuParser_R84 | EnjuParser_T81 | EnjuParser_T84 | arg1Of | oseltamivir,"," |
EnjuParser_R85 | EnjuParser_T85 | EnjuParser_T84 | arg2Of | zanamivir,"," |
EnjuParser_R86 | EnjuParser_T81 | EnjuParser_T86 | arg1Of | oseltamivir,"," |
EnjuParser_R87 | EnjuParser_T81 | EnjuParser_T87 | arg1Of | oseltamivir,etc. |
EnjuParser_R88 | EnjuParser_T79 | EnjuParser_T89 | arg1Of | inhibitors,"," |
EnjuParser_R89 | EnjuParser_T90 | EnjuParser_T89 | arg2Of | ganciclovir,"," |
EnjuParser_R90 | EnjuParser_T70 | EnjuParser_T91 | arg1Of | drugs,"," |
EnjuParser_R91 | EnjuParser_T93 | EnjuParser_T91 | arg2Of | and,"," |
EnjuParser_R92 | EnjuParser_T92 | EnjuParser_T93 | arg1Of | acyclovir,and |
EnjuParser_R93 | EnjuParser_T94 | EnjuParser_T93 | arg2Of | ribavirin,and |
EnjuParser_R94 | EnjuParser_T96 | EnjuParser_T95 | arg1Of | are,"," |
EnjuParser_R95 | EnjuParser_T91 | EnjuParser_T96 | arg1Of | ",",are |
EnjuParser_R96 | EnjuParser_T97 | EnjuParser_T96 | arg2Of | invalid,are |
EnjuParser_R97 | EnjuParser_T91 | EnjuParser_T97 | arg1Of | ",",invalid |
EnjuParser_R98 | EnjuParser_T97 | EnjuParser_T98 | arg1Of | invalid,for |
EnjuParser_R99 | EnjuParser_T99 | EnjuParser_T98 | arg2Of | 2019-nCoV,for |
EnjuParser_R100 | EnjuParser_T99 | EnjuParser_T100 | arg1Of | 2019-nCoV,and |
EnjuParser_R101 | EnjuParser_T102 | EnjuParser_T101 | arg1Of | recommended,not |
EnjuParser_R102 | EnjuParser_T99 | EnjuParser_T102 | arg2Of | 2019-nCoV,recommended |
LitCovid-ArguminSci
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T4 | 0-127 | DRI_Background | denotes | Antiviral drugs commonly used in clinical practice, including neuraminidase inhibitors (oseltamivir, paramivir, zanamivir, etc. |
T5 | 127-214 | DRI_Background | denotes | ), ganciclovir, acyclovir and ribavirin, are invalid for 2019-nCoV and not recommended. |
LitCovid-OGER
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 0-15 | CHEBI:36044 | denotes | Antiviral drugs |
T2 | 76-86 | CHEBI:35222 | denotes | inhibitors |
T3 | 88-99 | CHEBI:7798 | denotes | oseltamivir |
T4 | 112-121 | CHEBI:50663 | denotes | zanamivir |
T5 | 130-141 | CHEBI:465284 | denotes | ganciclovir |
T6 | 143-152 | CHEBI:2453 | denotes | acyclovir |
T7 | 157-166 | CHEBI:63580 | denotes | ribavirin |
T1 | 168-171 | SO:0001853 | denotes | are |
LitCovid-PubTatorCentral
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T6 | 88-99 | Chemical:MESH:D053139 | denotes | oseltamivir |
T7 | 101-110 | Chemical: | denotes | paramivir |
T8 | 112-121 | Chemical:MESH:D053243 | denotes | zanamivir |
T9 | 130-141 | Chemical:MESH:D015774 | denotes | ganciclovir |
T10 | 143-152 | Chemical:MESH:D000212 | denotes | acyclovir |
T11 | 157-166 | Chemical:MESH:D012254 | denotes | ribavirin |
LitCovid-sentences-v1
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
TextSentencer_T4 | 0-214 | Sentence | denotes | Antiviral drugs commonly used in clinical practice, including neuraminidase inhibitors (oseltamivir, paramivir, zanamivir, etc.), ganciclovir, acyclovir and ribavirin, are invalid for 2019-nCoV and not recommended. |
LitCovid-TimeML
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
tok77 | 0-9 | NNP | denotes | Antiviral |
tok78 | 10-15 | NNS | denotes | drugs |
tok79 | 16-24 | RB | denotes | commonly |
tok80 | 25-29 | VBN | denotes | used |
tok81 | 30-32 | IN | denotes | in |
tok82 | 33-41 | JJ | denotes | clinical |
tok83 | 42-50 | NN | denotes | practice |
tok84 | 50-51 | , | denotes | , |
tok85 | 52-61 | VBG | denotes | including |
tok86 | 62-75 | NN | denotes | neuraminidase |
tok87 | 76-86 | NNS | denotes | inhibitors |
tok88 | 87-88 | ( | denotes | ( |
tok89 | 88-99 | NN | denotes | oseltamivir |
tok90 | 99-100 | , | denotes | , |
tok91 | 101-110 | NN | denotes | paramivir |
tok92 | 110-111 | , | denotes | , |
tok93 | 112-121 | NN | denotes | zanamivir |
tok94 | 121-122 | , | denotes | , |
tok95 | 123-126 | FW | denotes | etc |
tok96 | 126-127 | . | denotes | . |
tok97 | 127-128 | ) | denotes | ) |
tok98 | 128-129 | , | denotes | , |
tok99 | 130-141 | NN | denotes | ganciclovir |
tok100 | 141-142 | , | denotes | , |
tok101 | 143-152 | NN | denotes | acyclovir |
tok102 | 153-156 | CC | denotes | and |
tok103 | 157-166 | NN | denotes | ribavirin |
tok104 | 166-167 | , | denotes | , |
tok105 | 168-171 | VBP | denotes | are |
tok106 | 172-179 | JJ | denotes | invalid |
tok107 | 180-183 | IN | denotes | for |
tok108 | 184-188 | CD | denotes | 2019 |
tok109 | 188-189 | : | denotes | - |
tok110 | 189-193 | NN | denotes | nCoV |
tok111 | 194-197 | CC | denotes | and |
tok112 | 198-201 | RB | denotes | not |
tok113 | 202-213 | VBD | denotes | recommended |
tok114 | 213-214 | . | denotes | . |
lookup19 | 30-32 | country_code | denotes | in |
lookup20 | 184-188 | year | denotes | 2019 |
event6 | 25-29 | OCCURRENCE | denotes | used |
event8 | 202-213 | OCCURRENCE | denotes | recommended |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T3 | 10-15 | Chemical | denotes | drugs | http://purl.obolibrary.org/obo/CHEBI_23888 |
T4 | 62-86 | Chemical | denotes | neuraminidase inhibitors | http://purl.obolibrary.org/obo/CHEBI_52425 |
T5 | 76-86 | Chemical | denotes | inhibitors | http://purl.obolibrary.org/obo/CHEBI_35222 |
T6 | 88-99 | Chemical | denotes | oseltamivir | http://purl.obolibrary.org/obo/CHEBI_7798 |
T7 | 112-121 | Chemical | denotes | zanamivir | http://purl.obolibrary.org/obo/CHEBI_50663 |
T8 | 130-141 | Chemical | denotes | ganciclovir | http://purl.obolibrary.org/obo/CHEBI_465284 |
T9 | 143-152 | Chemical | denotes | acyclovir | http://purl.obolibrary.org/obo/CHEBI_2453 |
T10 | 157-166 | Chemical | denotes | ribavirin | http://purl.obolibrary.org/obo/CHEBI_63580 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
33 | 62-75 | Gene | denotes | neuraminidase | Gene:4758 |
34 | 88-99 | Chemical | denotes | oseltamivir | MESH:D053139 |
35 | 101-110 | Chemical | denotes | paramivir | |
36 | 112-121 | Chemical | denotes | zanamivir | MESH:D053243 |
37 | 130-141 | Chemical | denotes | ganciclovir | MESH:D015774 |
38 | 143-152 | Chemical | denotes | acyclovir | MESH:D000212 |
39 | 157-166 | Chemical | denotes | ribavirin | MESH:D012254 |
40 | 184-193 | Species | denotes | 2019-nCoV | Tax:2697049 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T4 | 0-214 | Sentence | denotes | Antiviral drugs commonly used in clinical practice, including neuraminidase inhibitors (oseltamivir, paramivir, zanamivir, etc.), ganciclovir, acyclovir and ribavirin, are invalid for 2019-nCoV and not recommended. |